| Issue Type | XXXX |
|---|---|
| Country | Spain |
| Industry | XXXX |
| Region | XXXX |
| Maturity Date | 2026-09-30 |
| Par Value | 100000 |
| Callable | XXXX |
| Next Call Date | XXXX |
| Call Type | XXXX |
| Call Price (%) | XXXX |
| Series | XXXX |
| Class | XXXX |
| Maturity Structure | XXXX |
| Amount Outstanding (mil) | 298.99 |
| Coupon | 2.125 |
|---|---|
| Coupon Type | XXXX |
| Coupon Frequency | XXXX |
| First Coupon Date | XXXX |
| Last Coupon Date | XXXX |
| Sinking Fund | XXXX |
|---|---|
| Security | XXXX |
| Subordination | XXXX |
| Debt Type | XXXX |
| Issue Date | XXXX |
|---|---|
| Dated Date | XXXX |
| Issue Size (mil) | 298.990 |
| Min. Piece | XXXX |
| Min. Increment | XXXX |
This Almirall SA corporate note has a X.X % fixed rate coupon paid on a XXXX basis. It was issued on MAR 12, 2000 with an issue size of XXX million EUR and matures on DEC 9, 2000 with a last coupon date of FEB 28, 2020. |
Almirall SA, founded in 1943 and headquartered in Barcelona, Spain, is a global biopharmaceutical company dedicated to the research, development, and commercialization of innovative dermatology products. The company focuses on addressing unmet medical needs in skin diseases through its robust portfolio, which includes prescription drugs and consumer health products.